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We previously identified a group of 10 long-term survivors (LTS) of human immunodeficiency virus type 1 (HIV-1) infection.
Extensive biological analysis revealed that some of these individuals do well, at least in part, because they possess
weakened or attenuated viruses. Also, previously, to determine the genotype associated with the attenuated phenotype in
vivo, we characterized nef, vif, vpr, vpu, env, and LTR in our cohort of LTS. In this study, we analyzed gag and pol genes derived
from eight individuals in our cohort. For each subject, multiple full-length gag and pol clones were obtained for analysis. In
most cases, the sequences derived from the LTS had an intact open reading frame. At the protein level, there were no
discernible differences between the sequences derived from LTS and those derived from patients with AIDS. Thus, no
common defect in gag and pol was found in our cohort. One individual (subject SF), however, had only Gag-defective proviral
sequences (10 of 10) in his peripheral blood mononuclear cells. Furthermore, longitudinal studies of the samples collected
from SF over a 2-year period showed that all p17 gag clones sequenced (24 of 24) were defective due to G-to-A
hypermutations. This viral defect in Gag may provide the molecular basis for this individual’s extremely low viral load and
long-term asymptomatic state. These results, together with previous findings in our LTS cohort, reinforce the notion that it
is unlikely that a single common viral genetic determinant accounts for the lack of disease progression in all cases. Multiple
host and viral factors undoubtedly contribute to the well-being of LTS of HIV-1 infection. © 1998 Academic Press
INTRODUCTION
The mechanisms behind the significant variation ob-
served in the natural history of human immunodeficiency
virus type 1 (HIV-1) infection are unclear (Lifson et al.,
1988). In western countries, most HIV-1-infected individ-
uals develop AIDS about 10 years after seroconversion
(Munoz et al., 1989; Rutherford et al., 1990). Despite this
relatively long incubation period, progressing immuno-
deficiency actually occurs much earlier, typically seen as
a gradual loss of circulating CD41 T cells due to con-
tinuous high levels of viral replication (Ho et al., 1995; Wei
et al., 1995). More recent attention has been devoted to
a subset of HIV-1-infected individuals called long-term
survivors (LTS), who remain clinically asymptomatic and
immunologically normal despite a prolonged period of
HIV-1 infection (Cao et al., 1995; Pantaleo et al., 1995).
The fundamental question is why and how do these
individuals do so well. One possibility is that they are
part of a group of HIV-1-infected individuals who lie at the
tail end of a normal distribution curve and will eventually
develop AIDS. Another reasonable explanation is that
LTS are inherently more resistant to HIV-1 infection and
thus are less susceptible to HIV-1-mediated immune-
system destruction. Alternatively, they may have been
infected by an attenuated virus. Given these possibilities,
it is imperative to carefully study these individuals with
long-term nonprogressive infection. Such studies may
help us better understand the mechanisms by which
HIV-1 infection can be controlled.
We and others previously identified several groups of
LTS (Cao et al., 1995; Greenough et al., 1994; Kirchhoff et
al., 1995; Michael et al., 1995a; Pantaleo et al., 1995;
Sheppard et al., 1993). In general, these individuals were
found to have vigorous anti-HIV-1 immune responses,
including broadly reactive neutralizing antibodies and
potent CD81 T-cell suppressive activity mediated by
recently identified chemokines and/or other soluble fac-
tors (Cocchi et al., 1995; Moriuchi et al., 1996). These
findings suggest that some LTS do well, at least in part,
because of their active immune responses. Additionally,
low-to-undetectable levels of viral RNA were observed in
these individuals. In most of our cases, repeated at-
tempts to isolate infectious HIV-1 from LTS were unsuc-
cessful. In some cases, viral attenuation in vitro was also
observed (Cao et al., 1995; Learmont et al., 1992). These
results, coupled with the observation of low viral loads in
vivo, point to the possibility that viruses present in these
individuals may be attenuated or defective.
To define the genetic determinants of viral attenuation,
the HIV-1 genome, particularly the regulatory genes, were
analyzed in some LTS. Several groups concluded that ge-
netic defects in nef, vif, vpr, vpu, tat1, and rev1 may confer
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protection to the host (Deacon et al., 1995; Kirchhoff et al.,
1995; Mariani et al., 1996; Michael et al., 1995a; Premkumer
et al., 1996; Wang et al., 1996). In particular, a study of an
Australian cohort found that six LTS were infected with
nef-deleted HIV-1 from a single blood donor (Deacon et al.,
1995). This result is consistent with those of another study
in which the lack of disease progression was noted in
rhesus monkeys infected with nef-deleted simian immuno-
deficiency virus (Kestler et al., 1991). These findings strongly
support the thesis that a specific viral defect is responsible
for the absence of disease progression. In contrast, data
from our group and those from others showed that the
structure and functional properties of nef derived from LTS
are mostly intact (Huang et al., 1995a; Huang et al., 1995b;
Michael et al., 1995b). In addition, a detailed analysis of vif,
vpu, and vpr from our LTS revealed that most sequenced
clones were full-length, with an intact open reading frame
(Zhang et al., 1997b). These results suggest that mutations
in other regions of the HIV-1 genome may be involved in
viral attenuation. Indeed, four of our LTS had functional
abnormalities in the envelope glycoprotein of the env gene
(Connor et al., 1996). In studying the genotypic and pheno-
typic features of LTR from our LTS cohort, we found that, in
one case, multiple samples exhibited a high degree of
G-to-A mutations throughout the entire 59 LTR region. These
mutations, which led to functional defects in in vitro assays,
may explain the low viral load and prolonged asymptomatic
state of this individual (Zhang et al., 1997a).
In the present study, we sought to determine the ge-
notypic characterization of the gag and pol genes of
HIV-1, thereby completing the genetic analysis of the
entire viral genome in our cohort of LTS.
MATERIALS AND METHODS
Study subjects and samples
Peripheral blood mononuclear cells (PBMC) from 8 of
the 10 LTS in our cohort were available for analysis of the
HIV-1 gag and pol genes. At the time of sample collec-
tion, all 8 study subjects were classified as LTS, based
on duration of HIV-1 infection and CD41 T-cell counts.
The clinical profile of these subjects has been presented
in detail elsewhere (Cao et al., 1995). Blood samples
were obtained from each subject, and PBMC were puri-
fied by Ficoll-Hypaque gradient centrifugation. DNA was
then extracted using a DNA purification system (United
States Biochemical Corp.). Sequential blood samples
from 1 subject (SF) over a 2-year period (including No-
vember 1993, February 1995, and November 1995) were
also used.
PCR amplification of HIV-1 gag, pol, and p17
sequences
Because of the low viral load in these subjects, nested
PCR was used for all amplifications. In all cases, parallel
duplicate samples without DNA and DNA samples from
normal blood donors were used as negative controls.
The gag (G) and pol (P) primers used were designed to
amplify a fragment containing either the entire gag or the
entire pol. The primer sequences were as follows, with
their positions in the HIV-1 clone of the HXB2 genome
indicated in parentheses: The gag outer primers were G1
59-GCAGGACTCGGCTTGCTGAAGCGC-39 (688 to 711)
and G10 59-TACTGTATCATCTGCTCCTGTATC-39 (2347 to
2324), while the inner primers were G2 59-GCGGCGACT-
GGTGAGTACGCC-39 (733 to 753) and G9 59-TCCTTTAGT-
TGCCCCCCTATC-39 (2313 to 2293). The pol outer primers
were P1 59-GAAAAAGGGCTGTTGGAAATGTGG-39 (2015
to 2038) and P17 59-CCCCTAGTGGGATGTGTACTTC-
TG-39 (5220 to 5197), while the inner primers were P2
59-AGGAAGGACACCAAATGAAAG-39 (2041 to 2061) and
P16 59-GGATGAGTGCTTTCATAGTGA-39 (5185 to 5165).
For amplification of the p17 region, the outer primer pair
G1/M3 59-ATAGGGTAATTTTGGCTGACC-39 (1169 to 1189)
and the inner pair G2/M4 59-AGTTCTAGGTGATATGGC-
CTGATG-39 (1241 to 1218) were used.
For each sample, 1 to 2 mg of template DNA was used
in the first PCR to amplify gag or pol. Amplified se-
quences were verified using ethidium-bromide staining
after agarose gel electrophoresis and purified with the
Wizard PCR Preps DNA Purification System (Promega).
To improve sampling, PCR products of each sample
were generated from at least two independent amplifi-
cations before cloning. For amplification of the p17 re-
gion, an endpoint dilution method was employed (Sim-
monds et al., 1990). A pool of three amplicons was then
subjected to purification and cloning.
Molecular cloning, nucleotide sequencing, and
sequence analysis
The purified PCR products of gag, pol, and p17 were
molecularly cloned into a TA cloning vector, pCR-II (In-
vitrogen, Inc.). For each study subject, plasmid DNA of
multiple clones was prepared using the Wizard Mini-
preps DNA Purification System and subsequently se-
quenced by a model 377 automated DNA sequencer
(Applied Biosystems, Inc.). Ambiguous sequences were
verified by manual sequencing following the Sequenase
protocol (United States Biochemical Corp.). Nucleotide
sequences were aligned using the Clustal V program
(Higgins and Sharp, 1989). Pairwise distances among
sequences were estimated by the DNADIST program
implemented in the PHYLIP package (Version 3.5)
(Felsenstein, 1988). Phylogenetic analysis of the nucleo-
tide sequence data was carried out using the neighbor-
joining and parsimony method. Similar phylogenetic re-
lationships were also found in 1000 bootstrap replicates
of neighbor-joining trees (PHYLIP programs SEQBOOT
and CONSENSE).
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RESULTS AND DISCUSSION
Nucleotide sequence analysis of gag and pol in LTS
DNA was extracted from PBMC obtained from eight
LTS and their respective gag and pol sequences were
amplified by PCR. PCR products from the second round
of amplification were visualized by ethidium-bromide
staining after agarose gel electrophoresis. All study sam-
ples yielded positive results in PCR amplifications of gag
and pol regions. A PCR-positive signal was observed on
FIG. 1. Alignment and comparison of deduced amino-acid sequences of Gag and Pol. The translated sequences of gag and pol derived from LTS
and AIDS patients are aligned against the HIV-1 molecular clone HXB2, and their positions are underlined according to the HIV-1 HXB2 sequence.
Dots indicate identical residues, whereas individual variations are shown by the single amino acid letter. Gaps (-) are introduced to maximize
homology. ‘‘*’’ identifies the position of termination. The locations of putative functional motifs in Gag (A) and in Pol (B) are boxed and shown above
the aligned sequences. The protein-coding regions and protease cleavage sites on Gag and Pol are indicated by arrows.
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the gel as a single sharp band with approximately the
same length as a positive control of the HIV-1 clone
HXB2 (data not shown). No intrasample length polymor-
phism was observed in any of the samples examined by
the agarose gel mobility assay. In multiple independent
PCR amplifications, these parameters remained consis-
tent. These results suggest that there is no gross dele-
tion or insertion in gag and pol genes of our LTS cohort.
The homogeneity in the length of gag and pol genes in
LTS was further confirmed by sequence analysis. Four
clones of both gag and pol from each study subject were
randomly selected. A total of 32 full-length gag and 32
full-length pol sequences were obtained from 8 LTS (see
deduced amino-acid sequences in Figs. 1A and 1B). Con-
sistent with observations from the agarose gel analysis,
there was no obvious interpatient length variation. In gag,
FIG. 1—Continued
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most sequenced clones were the same length as the HIV-1
clone HXB2. The length variation observed in the se-
quences from subject DH was due to the in-frame addition
of six nucleotides in the length-variable region of gag (Fig.
1A). Intrasample length polymorphism was only observed
in subject RR; in four sequenced clones, two were shorter
by three nucleotides within the length-variable region (Fig.
1A). In pol, neither interpatient length variation nor in-
trasample length polymorphism was observed.
The features of genetic divergence of gag and pol
sequences among our LTS were also analyzed. The
average percentage of nucleotide variations for full-
length gag and full-length pol was determined by per-
forming pairwise comparisons of clones from each pa-
tient (Table 1). Within an individual, nucleotide dif-
ferences for full-length gag varied from 0.8% for subject
SF to 3.0% for subject CD, whereas the intrasample
diversity for full-length pol ranged from 0.4% in subject SF
to 2.1% in subject DH. Overall, the mean intersample
variation was 4.0% for gag and 4.4% for pol. Thus, there
were less differences in gag and pol sequences within a
single individual than among different individuals. The
bottom panel of Table 1 compares the mean intersubject
divergences of gag and pol from our LTS cohort with
some of the published sequences (HIV-1 isolates HAN,
HXB2, JRCSF, JRFL, MN, SF2, and YU10) obtained from
AIDS patients. As has been reported previously, the de-
gree of intersubject divergence between these two
groups is not significant, suggesting that the sequence
variations in gag and pol are probably not associated
with disease progression during the course of HIV-1
infection (Huang et al., 1995b; Leigh Brown, 1991; Mc-
Neary et al., 1992; Zhang et al., 1997b).
To define the evolutionary relationship of gag and pol
in our study subjects, phylogenetic trees of gag and pol
were constructed using all the DNA sequences derived
from the LTS and AIDS patients. Figures 2A and 2B show
neighbor-joining trees of gag and pol, in which the se-
quences were sorted by individual rather than disease
status. In other words, the sequences from individual LTS
were tightly grouped together and interdigitated with
those from patients with AIDS. Similar observations have
also been made for the nef, vif, vpu, and vpr sequences
derived from our LTS cohort (Huang et al., 1995b; Zhang
et al., 1997b). Taken together, these results strongly in-
dicate that nucleotide sequences from our LTS have no
distinct signature.
Features of deduced amino-acid sequences of gag
and pol in LTS
To investigate the features of amino acid sequences of
Gag and Pol derived from our cohort of LTS, we translated
all sequenced nucleotide sequences into amino acid se-
quences (Figs. 1A and 1B). Analysis of Gag amino acid
sequences revealed that 2 of 4 clones from subject BO
(BO6, BO10), 1 of 4 from LM (LM2), and all 4 from SF
(SF95/2-22, SF95/2-24, SF95/2-26, and SF95/2-30) had mu-
tations that would lead to the production of an aberrant gag
polyprotein. Proviral DNA sequences from SF were further
examined (see below). Therefore, other than SF, the defec-
tive rate was 10.7% in 28 full-length Gag derived from 7 LTS.
In Pol, 5 of 32 clones (15.6%) were defective (BO3, CD5,
CD8, RR8, and SF2). The other clones had open reading
frames for pol. Overall, the rate of defective gag–pol se-
quences does not appear to be inordinarily high. The de-
fects in gag and pol were due to the presence of premature
stop codons, the locations of which appear to be randomly
distributed throughout gag and pol.
To further delineate the features of gag and pol se-
quences derived from our cohort of LTS, the amino acid
sequences from all study subjects were aligned and
compared with corresponding sequences obtained from
AIDS patients (Figs. 1A and 1B). It is known that the HIV-1
Gag sequence contains several functional motifs, such
as the nuclear localization signal sequence (NLS), the
major homologue region (MHR), and zinc fingers. NLS at
the N-terminal of the matrix protein is responsible for
establishing infection in macrophages and quiescent T
lymphocytes, whereas MHR in capsid and zinc fingers in
nucleocapsid are involved in assembling mature viral
particles (Dorfman et al., 1994, 1993; Mammano et al.,
1994; Ottamnn et al., 1995; von Schwedler et al., 1994). As
shown in Fig. 1A, sequences in the Gag region were
relatively conserved among the sequences derived from
LTS and AIDS patients. In most cases, the sequences in
defined functional regions were highly conserved, al-
though a few changes in these regions were observed.
For instance, two of four clones from subject CD (CD9
and CD19) were found to have lysine (K) to asparagine
(N) changes in NLS (position 26). In subject BO, all four
TABLE 1
Comparison of Genetic Divergence of gag and pol Sequences
with and Between the LTS and AIDS Patients
Intrasubject
Divergence
gag pol
BO 0.026 0.020
CD 0.030 0.018
DH 0.023 0.021
LM 0.014 0.017
LSS 0.013 0.004
RP 0.003 0.006
RR 0.021 0.014
SF95/2 0.008 0.004
Inter-
LTS 0.040 0.044
AIDSa 0.044 0.034
a Sequences were obtained from GenBank including HIV-1 isolates
HAN, HXB2, JRCSF, JRFL, MN, RF, SF2, and YU10.
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FIG. 2. Phylogenetic analysis of gag and pol sequences. The phylogenetic relationships of gag and pol nucleotide sequences from LTS and AIDS
parients were analyzed using the PHYLIP package. The phylogenetic trees (A for gag and B for pol) were constructed by the neighbor-joining method.
Support values for the trees are based on 1000 boot-strap replicates. Individual sequences from LTS and patients with AIDS are represented by their
code at the end of each branch. The scale bar indicates 1% sequence divergence.
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clones had changes in MHR from isoleucine (I) to valine
(V) at position 288 and threonine (T) to isoleucine (I) at
position 306. However, four highly conserved residues
[glutamine (Q), glutamate (E), tyrosine (Y), and arginine
(R) at positions 290, 294, 299, and 302, respectively] that
were previously identified in MHR from different retrovi-
ruses (Mammano et al., 1994) were invariant in all of the
aligned sequences. No changes were observed in the
zinc-finger motif Cys-X4-Cys-X4-His-X4-Cys in the nucleo-
capsid domain of the Gag protein. The basic residue
between these two fingers was also highly conserved.
Most of the changes that have been observed so far in
functional regions were restricted to an interchange be-
tween positively charged residues; i.e., from lysine (K) to
arginine (R) or vice versa. In addition, the protease cleav-
age sites in the Gag region were also well preserved.
Thus, at the protein level, there were no discernible
differences between the Gag sequences derived from
seven of our LTS and those from AIDS patients.
The pol gene of HIV-1 encodes three functional en-
zymes that are required for virus replication: protease,
reverse transcriptase (RT), and integrase. To investigate
the genotypic features of these enzymes in LTS, we
completely sequenced full-length pol from our LTS co-
hort. Figure 1B shows the aligned amino acid sequences
of Pol from the LTS, along with some selected sequences
from AIDS patients. Examination of these aligned se-
quences revealed that the putative functional motifs in
protease, such as active site and substrate-binding re-
gions, were invariant. In RT, the active site (YMDD) in two
of four sequenced clones from LM (LM1 and LM4) were
changed to YVDD. Data from several studies suggest
that the YMDD motif is important for catalytic activity of
RT (Larder et al., 1989; Wakefield et al., 1992). HIV-1 with
a substitution of serine (S) or alanine (A) for methionine
(M) at this site replicates more slowly than wild-type
virus, whereas virus containing a substitution of glycine
(K) or proline (P) at this same position cannot replicate at
all (Larder et al., 1989). A methionine (M) to valine (V)
change appears to be associated with resistance to
several nucleoside analogs (Gu et al., 1992; Tisdale et al.,
1993). In vitro assays have shown that the catalytic ac-
tivity of RT in this mutant is similar to that of RT in
wild-type virus (Wilson et al., 1996). Thus, this particular
change at the active site should have no biological im-
pact on the functional properties of RT.
Phylogenetic comparison has identified two highly
conserved domains that are present in retroviral and
retrotransposon integrase (Engelman and Craigie, 1992;
Johnson et al., 1986; Khan et al., 1991; Kulkosky et al.,
1992). The conserved N-terminal domain is character-
ized by a zinc-finger-like motif in the format of HHCC
(positions 671, 675, 699, and 702); this was observed in
all the sequences derived from LTS and the AIDS pa-
tients. The most highly conserved region of retroviral
integrase lies in the central region of the protein, which
contains the integrase catalytic domain. This region is
defined by three acidic amino acid residues in a highly
conserved spatial arrangement known as the D, D-(35) E
motif (positions 723, 765, and 811), which is believed to
FIG. 3. Alignment and comparison of nucleotide sequences of p17 derived from LTS and patients with AIDS. Seven consensus nucleotide
sequences derived from LTS are represented as BO.con, CD.con, DH.con, LM.con, LSS.con, RP.con, and RR.con. In SF, individual sequences are
identified by the date of the blood sample from which they were amplified. These p17 sequences, together with some selected sequences from AIDS
patients, are aligned against the corresponding sequence of HIV-1 molecular clone HXB2. Numbers represent nucleotide positions in HIV-1 HXB2.
Gaps (-) are introduced to maximize homology. Dots indicate the identical nucleotide, and changes are shown by letters.
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comprise the active site. Certain single amino acid mu-
tations in either the aspartic acid (D) residue or the
glutamic acid (E) residue coordinately abolish 39 pro-
cessing, DNA strand transfer, and disintegration activi-
ties of HIV-1 in vitro (Leavitt et al., 1993; von Gent et al.,
1992). Particular mutants tested at position 811 contained
a substitution from glutamine (E) to alanine (A) or from
glutamine (E) to proline (P). Both mutations diminished
integrase activity in vitro and in vivo (Cannon et al., 1994;
Drelich et al., 1992; Leavitt et al., 1993). Interestingly,
changes from glutamine (E) to lysine (K) in all four se-
quenced clones were observed in subject RP (RP4, RP8,
RP9, and RP10) (Fig. 1B). The functional consequences, if
any, of these observed changes in integrase sequences
derived from subject RP warrant further investigation.
Detection of high prevalence of gag-defective
provirus in subject SF
One striking observation in gag derived from our LTS
cohort was the high prevalence of Gag-defective provi-
rus in subject SF (Fig. 1A). All four of the full-length gag
sequences had a methionine (M) to isoleucine (I) muta-
tion at the initiation site as well as multiple premature
stops throughout the gag coding region. All these muta-
tions can be attributed to G-to-A nucleotide substitutions.
FIG. 3—Continued
45gag AND pol SEQUENCES FROM HIV-1 SURVIVORS
Interestingly, no corresponding defect was found in the
Pol region of the same subject (Fig. 1B).
It is known that HIV-1 RT lacks 39 exonucleolytic ac-
tivity. Consequently, RT-catalyzed polymerization errors
occur during reverse transcription. One of the more re-
markable phenomena associated with reverse transcrip-
tion is G-to-A hypermutation, in which hundreds of tem-
plate G residues may be monotonously substituted by A
(Borman et al., 1995; Fitzgibbon et al., 1993; Pathak and
Temin, 1990; Sabino et al., 1993; Vartanian et al., 1991). As
a result, the change from a tryptophan codon (W, TGG) to
a stop codon (TAG) would presumably make the virus
defective. Based on the observation of hypermutation in
gag from SF, we questioned whether this high preva-
lence of G-to-A mutation is a true phenomenon or the
result of reamplification of a single defective proviral
genome. To answer this question, six additional full-
length gag clones from the same sample (SF) collected
in February 1995 were sequenced and analyzed. Very
similar results were obtained (data not shown). None of
these additional clones contained an intact open-reading
frame of gag. Among the 10 full-length gag sequences
from SF, 6 different variants were observed. Thus, G-to-A
hypermutation in gag derived from SF is not merely the
result of PCR amplification of a single defective proviral
genome.
To address this question further, two additional PBMC
samples collected 2 years apart (November 1993 and
November 1995) and an aliquoted PBMC sample from
February 1995 were analyzed. In this case, we attempted
to amplify multiple proviral genomes from a small frag-
ment of gag (p17) using a limiting dilution technique.
Following amplification, at least three amplicons were
pooled and subsequently cloned. Eight clones of p17
from the same sample were sequenced. A total of 24
clones of p17 derived from SF at three different time
points were aligned with the individual consensus p17
sequences derived from other LTS as well as the corre-
sponding sequences from patients with AIDS. As shown
in Fig. 3, multiple variants from the same sample (SF)
were amplified. We observed a high prevalence of G-to-A
hypermutations in all the sequenced clones collected
over the two years.
The average frequency of nucleotide A in the p17 of
LTS and AIDS patients was 0.398. The frequencies of A
in p17 derived from SF at three different time points were
0.483, 0.491, and 0.462 (Table 2). These numbers were
significantly higher than those found in other HIV-1 iso-
lates (P , 0.01). At the protein level, because of prema-
ture termination, none of the clones was intact. Interest-
ingly, the pattern of G-to-A hypermutation alters over
time. For example, the initiation codon of p17 was pre-
served in all clones from a sample collected at an early
time point. Over time, mutations occurred that impaired
the initiation codon for all of the p17 clones that were
observed. Moreover, the frequency of A in the November
1995 sample was 0.462, a value lower than that of the
November 1993 sample (0.483). Also, the February 1995
sample had a frequency of A of 0.491, a value higher than
that of November 1993. This irregular pattern indicates
that the G-to-A hypermutation in p17 of SF did not result
from an accumulation of mutations but rather from ran-
dom occurrences.
Presently, the mechanism of the high prevalence of
Gag-defective provirus in subject SF is unknown. Defects
in the RT, which may have led to the high rate of G-to-A
mutation, were not observed in multiple clones collected
at different time points of the same subject (data not
shown). Studies of proviral DNA sequences from PBMC
may not directly represent actively replicating viruses.
We attempted to isolate viral RNA from plasma samples
from this individual. However, due to the extremely low
viral load observed in SF, multiple attempts of reverse
transcription and PCR amplification of p17 sequences
were unsuccessful. Moreover, we repeatedly were un-
able to isolate culturable virus from this individual (Cao
et al., 1995, and unpublished results). Further study of the
virus from this subject’s lymphoid organs may help us
understand the biological nature of this phenomenon.
Nevertheless, the high prevalence of defective viruses
may provide the possible explanation for the well-being
of subject SF.
Recently, much attention has been focused on LTS of
HIV-1 infection. Several studies have shown that some
LTS do well because of their highly effective immune
responses against HIV-1 (Cao et al., 1995; Montefiori et
TABLE 2
G, A Base Composition of HIV-1 p17
Samples No. of A Frequency No. of G Frequency
BO.con 158 0.396 103 0.258
CD.con 159 0.398 99 0.248
DH.con 162 0.400 104 0.257
LM.con 158 0.396 100 0.251
LSS.con 157 0.393 104 0.261
RP.con 159 0.398 99 0.248
RR.con 162 0.406 99 0.248
HivHAN 160 0.401 101 0.253
HivHXB2 161 0.404 97 0.243
HivJRCSF 159 0.398 98 0.246
HivJRFL 158 0.402 98 0.249
HivMN 167 0.409 100 0.245
HivRF 160 0.401 98 0.246
HivSF2 159 0.393 104 0.257
HivYU10 156 0.391 102 0.256
Mean 160 0.398 100 0.251
SF93/11a 192 0.483 65 0.164
SF95/2a 195 0.491 62 0.156
SF95/11a 185 0.462 74 0.185
a Numbers represent the average value of eight p17 clones se-
quenced from the same sample.
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al., 1996; Rinaldo et al., 1995). Conversely, other studies
have found a relatively attenuated strain of HIV-1 or
viruses defective in nef in LTS (Deacon et al., 1995;
Kirchhoff et al., 1995; Mariani et al., 1996). Studies from
our LTS cohort revealed, on the one hand, vigorous
anti-HIV-1 immune responses and, on the other hand,
culturable viruses often replicate very poorly in vitro. The
latter result suggests that some LTS may have been
infected with weakened or attenuated viruses. Alterna-
tively, prolonged immunity-mediated viral suppression
could induce a viral quasispecies with a more attenuated
phenotype than that of the initial infecting viruses, as has
been proposed (Michael et al., 1995a).
In an attempt to elucidate the possible molecular
mechanisms of viral attenuation in our cohort of LTS, we
have systematically PCR amplified the quasispecies of
proviral genomes of HIV-1 derived from PBMC of our
study subjects for genetic analysis. One limitation of this
experimental approach is that the amplified proviral se-
quences could be derived from either infectious or non-
infectious viruses. Ideally, sequences derived from infec-
tious viruses should be studied. But due to the low viral
load in these LTS, our efforts to recover viral RNA from
plasma were unsuccessful. Nevertheless, we believe
that genetic analysis of proviral DNA sequences could
still provide valid information on HIV-1 in vivo. With the
completion of this study, we now have characterized the
entire HIV-1 genome in our cohort of LTS (Table 3). At the
genetic level, the nef, vpu, vpr, and vif genes of HIV-1
were intact. No common genetic basis for viral attenua-
tion has been identified; however, genetic defects in the
LTR region and functional abnormalities in Env have
been previously found in some individuals (Connor et al.,
1996; Zhang et al., 1997a). In the current study, in most
cases, the gag and pol sequences from our LTS had an
intact open-reading frame. At the protein level, there
were no discernible differences between the sequences
derived from LTS and those from AIDS patients. In one
case (SF), however, we identified a high prevalence of
G-to-A hypermutation in gag sequences. Longitudinal
studies of the samples collected from SF also confirmed
that this hypermutation did not result from sampling
and/or artifacts generated during PCR amplification. This
defect in Gag may contribute to this subject’s extremely
low viral load and his long-term asymptomatic state.
Together with previous studies of our LTS cohort, these
results reinforce the notion that it is unlikely that a single
common genetic determinant will account for lack of
disease progression in all cases. Multiple factors un-
doubtedly contribute to the well-being of LTS of HIV-1
infection.
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Note added in proof. Overall, 2 (RP and SF) of our 10 LTS have
defective viruses. Testing for the D32 mutation in the chemokine re-
ceptors CCR5 (Dean et al., 1996; Huang et al., 1996) and for the 64I
mutation in CCR2 (Smith et al., 1997) was also performed on the DNA
of each of our LTS. Only 4 had wild-type CCR5 and CCR2. Three (DH,
LM, and RP) are heterozygous for the D32 mutation in CCR5, whereas
5 (DH, LM, LSS, RR, and SF) are heterozygous for the 64I mutation in
CCR2. Taken together, only 4 LTS (BO, CD, D, and E) failed to have at
least one viral or host factor as an explanation for their initial well
being; interestingly, 3 (BO, CD, and D) of these have recently pro-
gressed to meet the clinical definition of AIDS.
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